Trials / Unknown
UnknownNCT04845997
COVID-19 Vaccination in Patients With Rheumatic Diseases
NATIONAL VACCINATION REGISTRY FOR SARS-CoV-2 IN PATIENTS WITH RHEUMATIC DISEASES OF THE ARGENTINE SOCIETY OF RHEUMATOLOGY
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,000 (estimated)
- Sponsor
- Sociedad Argentina de Reumatologia · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Argentine Society of Rheumatology (SAR) set out to develop a national register of patients with rheumatic diseases who have received a SARS-CoV-2 vaccine in order to assess their efficacy and safety in this population.
Detailed description
This is an observational, longitudinal, multicenter study, including patients with rheumatic diseases who have been vaccinated for COVID-19 in Argentine or any country. Patients will be followed for 12 months and two evaluations will be performed, one at baseline and the other after the follow-up time is completed. The aim of this registry is to evaluate the efficacy and safety of the SARS-CoV-2 vaccines in patients with rheumatic diseases.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | COVID-19 Vaccine | Patients with rheumatic diseases who have been vaccinated for COVID-19 |
Timeline
- Start date
- 2021-07-01
- Primary completion
- 2023-06-30
- Completion
- 2023-12-31
- First posted
- 2021-04-15
- Last updated
- 2023-02-01
Locations
2 sites across 1 country: Argentina
Source: ClinicalTrials.gov record NCT04845997. Inclusion in this directory is not an endorsement.